BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use.
Giovanni GrandiFrancesca MonariValentina Boggio SolaLaura CortesiAngela TossMaria Chiara Del SavioChiara MelottiMaria Grazia CenturioniClaudio GustavinoLiliana VarescoFabio FacchinettiFabio BarraPublished in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2022)
Investing time and effort in transmitting the correct key messages about oncological risk related to CHC use could potentially increase their use in BRCA mutation carriers.